Research 2026-09-27· Cancer Network
AI's Evolution in Oncology: Industrialization, Trials, and Outcomes in 2026
2026 marks the 'year of AI industrialization in oncology,' with health and pharmaceutical companies investing in foundational models to accelerate drug discovery. AI is impacting cancer trials, workflows, and patient outcomes by compressing discovery cycles from years to months or weeks.
Full write-up is being prepared. Meanwhile, see more coverage on the AI News feed.